Call to Action: End Hepatitis C Health Disparities for African Americans
Hepatitis C is a major racial/ethnic health disparity – particularly for African Americans.
African American mortality related to the hepatitis C virus (HCV) is almost double the rates for non-Hispanic white Americans, and chronic liver disease is a leading cause of death among African Americans ages 45-64. African Americans are twice as likely to have ever been infected with hepatitis C compared to whites.
With new treatments on the horizon, we have the tools to end the hepatitis C epidemic. But we need to make sure these tools and resources reach all communities. The next federal Viral Hepatitis Action Plan must have a strong focus on ending hepatitis C health disparities for African Americans.
Federal officials are working on a new Viral Hepatitis Action Plan to outline strategies and priorities for 2014-2016. Join us in calling upon Dept. of Health & Human Services Secretary Sebelius to ensure that the next Viral Hepatitis Action Plan includes a strong focus on ending disparities for African Americans.
We’re seeking organizational and individual sign-ons to the letter below – deadline COB Friday, September 13th.
Thanks for your support, and please help us spread the word!
If I took a lot of condoms, they would arrest me. If I took a few or only one, I would run out and not be able to protect myself. How many times have I had unprotected sex because I was afraid of carrying condoms? Many times.
–Anastasia L., sex worker (Human Rights Watch)
Harm Reduction Coalition strongly supports AB 336 (Ammiano), that would ensure that possession of one or more condoms shall not be used as evidence of soliciting or engaging in prostitution. Please send a letter to your state legislators in support.
Despite our success with decreasing heroin overdose deaths, prescription opioid overdoses continue to rise, making overdose the leading cause of accidental death. Harm Reduction Coalition has been working with Rep Tom Ammiano to expand naloxone distribution in California through legislation (AB 635 – Overdose Treatment Liability Act) that would encourage health care providers to begin prescribing naloxone to patients on chronic opioid pain medications as well as expand the pilot liability protection for programs and people who use naloxone statewide. If you are a California resident, please send a letter to your representatives in support of AB 635. You can edit the letter or send it as written.